Fundz

Apnimed Inc. Appoints Kevin Lind as Chief Executive Officer

PUBLIC · APMDJun 08, 2026

Position

Chief Executive Officer

Company

Apnimed

Kevin Lind
CambridgeManufacturingHealthcare

Description

Apnimed Inc. has appointed Kevin Lind as Chief Executive Officer, effective June 2, 2026. He succeeds Lawrence 'Larry' G

Quick answer

Apnimed Inc. Appoints Kevin Lind as Chief Executive Officer (June 8, 2026). Apnimed is based in Cambridge, Massachusetts, United States.

Who is the new Chief Executive Officer at Apnimed?
Apnimed named Kevin Lind Chief Executive Officer, announced June 8, 2026.
What did Apnimed announce on June 8, 2026?
Apnimed Inc. has appointed Kevin Lind as Chief Executive Officer, effective June 2, 2026.
What does Apnimed do?
Apnimed is a clinical-stage pharmaceutical company working to transform the treatment of sleep apnea based on a simple idea – patients with obstructive sleep apnea could benefit from treatment with a safe and effective...
Where is Apnimed based?
Apnimed is based in Cambridge, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
Merck (June 9, 2026), Endovia Health Sciences, Inc. (June 12, 2026), Hadrian (June 15, 2026) and JenaValve (May 28, 2026) also announced leadership changes within 45 days of Apnimed.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Manufacturing

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Apnimed, and when

A new leader at Apnimed brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Apnimed raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Apnimed, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Apnimed. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Apnimed

Location

39 John F. Kennedy Street, 4th Fl

Cambridge, Massachusetts, United States

About

Apnimed is a clinical-stage pharmaceutical company working to transform the treatment of sleep apnea based on a simple idea – patients with obstructive sleep apnea could benefit from treatment with a safe and effective oral medication dosed once daily at bedtime. Apnimed’s lead development program targets the neurologic control of upper airway muscles to maintain an open airway during sleep. Based in Cambridge, Mass., the company is developing a portfolio of novel pharmacologic therapies for sleep apnea and related disorders. Learn more at apnimed.com or follow us on Twitter and LinkedIn.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Apnimed changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Graham
Likely contact at this company
••••••••@••••••••

See Graham's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Apnimed's next move

Learn about Strategic plan

Apnimed changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.